Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

(2012) Trine Folseraas et al.   JOURNAL OF HEPATOLOGY

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

(2011) J. Torres et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intestinal Inflammation and Cancer

(2011) Thomas A. Ullman et al.   GASTROENTEROLOGY

Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location

(2011) Robert Goldstone et al.   GASTROINTESTINAL ENDOSCOPY

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

(2011) R. M. Gadaleta et al.   GUT

Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance

(2011) Robert Goldstone et al.   INFLAMMATORY BOWEL DISEASES

Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis

(2011) Sigurd Lax et al.   INTERNATIONAL JOURNAL OF CANCER

Early-stage formation of an epigenetic field defect in a mouse colitis model and non-essential roles of T- and B-cells in DNA methylation induction

(2011) M Katsurano et al.   ONCOGENE

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease

(2011) Rian M. Nijmeijer et al.   PLoS One

Bile acids and colon cancer: Solving the puzzle with nuclear receptors

(2011) Chiara Degirolamo et al.   TRENDS IN MOLECULAR MEDICINE

American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

(2009) Douglas K Rex et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages

(2009) Barbara Renga et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis

(2009) M. M.H. Claessen et al.   INFLAMMATORY BOWEL DISEASES

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

(2009) P. Vavassori et al.   JOURNAL OF IMMUNOLOGY

Nuclear Bile Acid Receptor FXR Protects against Intestinal Tumorigenesis

(2008) S. Modica et al.   CANCER RESEARCH

Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development

(2008) R. R.M. Maran et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS